In the US, Streptase (streptokinase systemic) is a member of the drug class thrombolytics and is used to treat Arterial Thrombosis, Deep Vein Thrombosis, Heart Attack, Pulmonary Embolism and Thrombotic/Thromboembolic Disorder.
- STREPTASE INJECTION 1 500 000 IU POWDER FOR SOLUTION FOR INFUSION (Leaflet)
- STREPTASE INJECTION 250 000 IU POWDER FOR SOLUTION FOR INFUSION (Leaflet)
- STREPTASE INJECTION 750 000 IU POWDER AND SOLUTION FOR INFUSION (Leaflet)
Ingredient matches for Streptase
Streptokinase is reported as an ingredient of Streptase in the following countries:
- Bosnia & Herzegowina
- Croatia (Hrvatska)
- Hong Kong
- South Africa
- United Kingdom
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.